Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Wake Forest University Health Sciences
New York Medical College
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
FBD Biologics Limited
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Seagen Inc.
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
Medical College of Wisconsin
Pfizer
St. Petersburg State Pavlov Medical University
University College, London
VIVUS LLC
City of Hope Medical Center
M.D. Anderson Cancer Center
Baylor College of Medicine
University of Nebraska
Wake Forest University Health Sciences
Thomas Jefferson University
Children's Cancer Group, China